Overview
Christopher Hoimes is an Internal Medicine provider in Durham, North Carolina. Dr. Hoimes is rated as an Experienced provider by MediFind in the treatment of Neuroendocrine Tumor. His top areas of expertise are Urothelial Cancer, Bladder Cancer, Muscle Invasive Bladder Cancer, Prostate Cancer, and Orchiectomy. Dr. Hoimes is currently accepting new patients.
His clinical research consists of co-authoring 71 peer reviewed articles and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles and participated in 3 clinical trials in the study of Neuroendocrine Tumor.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- MEDICARE MAPD
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- HMO
- POS
- INSURANCE PLAN
- MEDICARE MAPD
- OTHER COMMERCIAL
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
20 Duke Medicine Cir, Clinic 5 Cancer Center, Durham, NC 27710
2351 Erwin Rd, Durham, NC 27705
2301 Erwin Rd, Durham, NC 27705
Additional Areas of Focus
Dr. Hoimes has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
7 Clinical Trials
Duke Cancer Center
Diane Reidy is a Hematologist Oncology specialist and a Hematologist in Durham, North Carolina. Dr. Reidy is rated as an Elite provider by MediFind in the treatment of Neuroendocrine Tumor. Her top areas of expertise are Neuroendocrine Tumor, Pancreatic Islet Cell Tumor, Pancreatic Cancer, Pancreaticoduodenectomy, and Liver Embolization.
Duke Cancer Center
Michael Morse is a Hematologist Oncology specialist and an Oncologist in Durham, North Carolina. Dr. Morse has been practicing medicine for over 35 years and is rated as a Distinguished provider by MediFind in the treatment of Neuroendocrine Tumor. His top areas of expertise are Neuroendocrine Tumor, Fibrolamellar Carcinoma, Cholangiocarcinoma (Bile Duct Cancer), Appendix Cancer, and Liver Embolization.
University Of North Carolina At Chapel Hill
Hanna Sanoff is a Hematologist Oncology specialist and an Oncologist in Chapel Hill, North Carolina. Dr. Sanoff is rated as a Distinguished provider by MediFind in the treatment of Neuroendocrine Tumor. Her top areas of expertise are Colorectal Cancer, Fibrolamellar Carcinoma, Liver Cancer, Familial Colorectal Cancer, and Pancreaticoduodenectomy. Dr. Sanoff is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Urothelial CancerDr. Hoimes isElite. Learn about Urothelial Cancer.
- Distinguished
- Bladder CancerDr. Hoimes isDistinguished. Learn about Bladder Cancer.
- Chromophobe Renal Cell CarcinomaDr. Hoimes isDistinguished. Learn about Chromophobe Renal Cell Carcinoma.
- Muscle Invasive Bladder CancerDr. Hoimes isDistinguished. Learn about Muscle Invasive Bladder Cancer.
- Prostate CancerDr. Hoimes isDistinguished. Learn about Prostate Cancer.
- Renal Cell Carcinoma (RCC)Dr. Hoimes isDistinguished. Learn about Renal Cell Carcinoma (RCC).
- WT1-Related Wilms Tumor SyndromesDr. Hoimes isDistinguished. Learn about WT1-Related Wilms Tumor Syndromes.
- Advanced
- Non-Muscle Invasive Bladder Cancer
- Upper Tract Urothelial Carcinoma (UTUC)
- Wilms TumorDr. Hoimes isAdvanced. Learn about Wilms Tumor.
- Experienced
- Adrenocortical CarcinomaDr. Hoimes isExperienced. Learn about Adrenocortical Carcinoma.
- ALK-Positive Non-Small Cell Lung CancerDr. Hoimes isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- ChoriocarcinomaDr. Hoimes isExperienced. Learn about Choriocarcinoma.
- Classical Hodgkin LymphomaDr. Hoimes isExperienced. Learn about Classical Hodgkin Lymphoma.
- Lung AdenocarcinomaDr. Hoimes isExperienced. Learn about Lung Adenocarcinoma.
- Lung CancerDr. Hoimes isExperienced. Learn about Lung Cancer.